Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein L1 | 0.547 | 0.615 | 5.1E-06 |
|
group | 0.100 | None | 0.955 | 156 | 1 | 2010 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.400 | None | 0.908 | 142 | 6 | 1994 | 2020 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
group | 0.400 | None | 0.960 | 100 | 1 | 1980 | 2020 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
group | 0.400 | None | 0.973 | 74 | 1 | 1978 | 2020 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.400 | None | 0.941 | 68 | 4 | 1995 | 2019 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
group | 0.200 | None | 0.957 | 46 | 3 | 2002 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 0.974 | 39 | 0 | 2001 | 2019 | ||||||||
|
solute carrier family 5 member 2 | 0.499 | 0.769 | 4.9E-14 |
|
group | 0.100 | None | 0.971 | 34 | 0 | 2017 | 2020 | ||||||||
|
uromodulin | 0.520 | 0.846 | 3.1E-17 |
|
group | 0.700 | None | 1.000 | 34 | 3 | 1993 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.100 | None | 0.879 | 33 | 3 | 1999 | 2017 | ||||||||
|
cystatin C | 0.436 | 0.808 | 3.9E-03 |
|
group | 0.400 | None | 1.000 | 28 | 0 | 2006 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.300 | None | 0.893 | 28 | 0 | 1994 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 1.000 | 26 | 1 | 1997 | 2019 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
group | 0.100 | None | 0.958 | 24 | 0 | 1998 | 2019 | ||||||||
|
IgA nephropathy | 0.524 | 0.808 |
|
group | 0.100 | None | 0.917 | 24 | 0 | 1983 | 2020 | |||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.958 | 24 | 1 | 2001 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.100 | None | 0.955 | 22 | 0 | 1995 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.864 | 22 | 0 | 2003 | 2019 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
group | 0.400 | None | 1.000 | 21 | 0 | 2006 | 2019 | ||||||||
|
fibroblast growth factor 23 | 0.460 | 0.731 | 3.1E-02 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 2003 | 2019 | ||||||||
|
Rap guanine nucleotide exchange factor 5 | 0.524 | 0.769 | 0.98 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 1983 | 2020 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
group | 0.600 | None | 0.950 | 20 | 1 | 1997 | 2018 | ||||||||
|
NPHS2 stomatin family member, podocin | 0.576 | 0.538 | 7.2E-09 |
|
group | 0.100 | None | 1.000 | 20 | 2 | 2003 | 2019 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
group | 0.200 | None | 1.000 | 18 | 3 | 2000 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 2005 | 2020 |